Updated Jul 16, 2026
Magovcevic-Liebisch Ivana has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $28K. Historical track record: 3/5 stars across 3 tracked purchases.

Ivana Magovcevic-Liebisch is a corporate executive known for her roles as President and CEO at Acrivon Therapeutics, Inc. and other biotechnology firms. She has significant experience in the life sciences sector, contributing to the advancement of therapeutic innovations.
| Role | Insider |
|---|---|
| Notability | 30/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★☆☆ (3/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 6667% |
| 90-day win rate | 10000% |
| Avg 5-day return | -288.24% |
| Avg 30-day return | +673.10% |
| Avg 90-day return | +1275.21% |
| Best 30-day return | +2530.12% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-20 | ACRV | Acrivon Therapeutics, Inc. | A — Grant or award | 9.4K | $0.00 | |
| 2026-01-15 | QTRX | Quanterix Corp | A — Grant or award | 23.4K | $0.00 | |
| 2025-08-05 | VIGL | Vigil Neuroscience, Inc. | D — Derivative transaction | 222.7K | — | |
| 2024-12-19 | VIGL | Vigil Neuroscience, Inc. | P — Open-market purchase | 5.0K | $1.68 | $8K |
| 2024-12-18 | VIGL | Vigil Neuroscience, Inc. | P — Open-market purchase | 5.0K | $1.67 | $8K |
| 2024-12-05 | VIGL | Vigil Neuroscience, Inc. | P — Open-market purchase | 5.0K | $2.34 | $12K |
| 2024-10-03 | QTRX | Quanterix Corp | A — Grant or award | 12.8K | $0.00 |
Ivana Magovcevic-Liebisch is a corporate executive known for her roles as President and CEO at Acrivon Therapeutics, Inc. and other biotechnology firms. She has significant experience in the life sciences sector, contributing to the advancement of therapeutic innovations.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 3 open-market purchases ($28K) and 0 open-market sales () across all tracked filings.
Across 3 tracked purchases, Magovcevic-Liebisch Ivana averaged +673.1% avg 30-day return with a 6667% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Magovcevic-Liebisch Ivana profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.